Cogent Biosciences (COGT) Other Non-Current Assets (2017 - 2026)

Cogent Biosciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $416000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 91.44% year-over-year to $416000.0; the TTM figure through Mar 2026 stood at $416000.0 (down 91.44% YoY), while the FY2025 annual figure was $416000.0, down 91.44% from the prior year.
• Other Non-Current Assets was $416000.0 for Q1 2026 at Cogent Biosciences, roughly flat from $416000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.9 million in Q2 2022 to a low of $416000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $4.1 million across 5 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 290.04% in 2022, then plunged 91.44% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $4.7 million in 2022, then gained by 2.51% to $4.9 million in 2023, then decreased by 0.04% to $4.9 million in 2024, then slumped by 91.44% to $416000.0 in 2025, then changed by 0.0% to $416000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $416000.0 (Q1 2026), $416000.0 (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.